Skip to main content

Effects of Amyloid-β Peptide on the Biology of Human Neural Stem Cells

  • Protocol
  • First Online:
Amyloid Proteins

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1779))

Abstract

The amyloid -β peptide (Aβ) is the main component of the amyloid plaques in Alzheimer’s disease (AD). It has been widely demonstrated that Aβ is toxic to neurons and is associated with AD pathology. However, Aβ also appears to have an important biological function both in the adult brain and throughout embryonic development of the nervous system, acting as a trophic factor at low concentrations.

It is known that Neural Stem Cells (NSCs) are capable of self-renewal and differentiate into functional glial and neuronal cells. Therefore, human NSCs may be a hope for future therapeutic application in neurodegenerative diseases such as AD. The effects of Aβ peptides on NSCs are still not well understood and remain controversial.

In this chapter we outline the materials and methods used for the culture and differentiation of hNS1 cells, a cell line of human NSCs. We describe the preparation of different forms (monomeric, oligomeric and fibrillary) of Aβ peptide and subsequent cell treatment, followed by the analysis of the effects on toxicity, cell proliferation and cell fate specification of hNS1 cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zhang YW, Thompson R, Zhang H et al (2011) APP processing in Alzheimer's disease. Mol Brain 4:3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Peña-Casanova J (1999) Enfermedad de Alzheimer. Del diagnóstico a la terapia: conceptos y hechos. Barcelona: Fundación “La Caixa”

    Google Scholar 

  3. Serrano-Pozo A, Frosch MP, Masliah E et al (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Manzano-León N, Mas-Oliva J (2006) Estrés oxidativo, péptido β-amiloide y enfermedad de Alzheimer. Gac Med Mex 142(3):229–238

    PubMed  Google Scholar 

  5. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580):353–356

    Article  CAS  Google Scholar 

  6. Pérez V (2014) Identificación de regiones clave en el proceso de agregación y citotoxicidad del péptido β-amiloide. Tesis de máster. Universidad Autónoma de Nuevo León. Departamento de Bioquímica y Medicina Molecular, México

    Google Scholar 

  7. Dahlgren KN, Manelli AM, Stine WB Jr et al (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277(35):32046–32053

    Article  CAS  PubMed  Google Scholar 

  8. Pearson HA, Peers C (2016) Physiological roles for amyloid beta peptides. J Physiol 575(Pt 1):5–10

    Google Scholar 

  9. Cárdenas-Aguayo MC, Silva-Lucero MC, Cortes-Ortiz M et al (2014) Physiological role of amyloid Beta in neural cells: the cellular trophic activity, neurochemistry. In: Heinbockel T (ed). InTech. https://doi.org/10.5772/57398

  10. Chasseigneaux S, Allinquant B (2012) Functions of Aβ, sAPPα and sAPPβ: similarities and differences. J Neurochem 120(Supl.1):99–108

    Article  CAS  PubMed  Google Scholar 

  11. Martínez-Morales PL, Revilla A, Ocaña I et al (2013) Progress in stem cell therapy for major human neurological disorders. Stem Cell Rev Rep 9(5):685–699

    Article  CAS  Google Scholar 

  12. Lindvall O, Kokaia Z (2010) Stem cells in human neurodegenerative disorders—time for clinical translation? J Clin Invest 120(1):29–40

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Martínez-Morales PL, Liste I (2012) Stem cells as in vitro model of Parkinson’s disease. Stem Cells Int 2012:980941. Epub 2012 Apr 30. PMID: 22619684

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Villa A, Snyder EY, Vescovi A et al (2000) Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Exp Neurol 161(1):67–84

    Article  CAS  PubMed  Google Scholar 

  15. Villa A, Navarro-Galve B, Bueno C et al (2004) Long-term molecular and cellular stability of human neural stem cell lines. Exp Cell Res 294(2):559–570

    Article  CAS  PubMed  Google Scholar 

  16. Cummings BS, Schnellmann RG (2004) Measurement of cell death in mammalian cells. Curr Protoc Pharmacol. Chapter 12: Unit 12.8. doi: https://doi.org/10.1002/0471141755.ph1208s25

  17. Porter AG, Jänicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6(2):99–104

    Article  CAS  PubMed  Google Scholar 

  18. Bullwinkel J, Baron-Lühr B, Lüdemann A et al (2006) Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol 206(3):624–635

    Article  CAS  PubMed  Google Scholar 

  19. Lehner B, Sandner B, Marschallinger J et al (2011) The dark side of BrdU in neural stem cell biology: detrimental effects on cell cycle, differentiation and survival. Cell Tissue Res 345(3):313–328. https://doi.org/10.1007/s00441-011-1213-7

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to thank members of their laboratory for their research work and fruitful discussions. Research at the authors’ laboratory was funded by the MICINN-ISCIII (PI-10/00291 and MPY1412/09), MINECO (SAF2015-71140-R) and Comunidad de Madrid (NEUROSTEMCM consortium; S2010/BMD-2336).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isabel Liste .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Bernabeu-Zornoza, A., Coronel, R., Lachgar, M., Palmer, C., Liste, I. (2018). Effects of Amyloid-β Peptide on the Biology of Human Neural Stem Cells. In: Sigurdsson, E., Calero, M., Gasset, M. (eds) Amyloid Proteins. Methods in Molecular Biology, vol 1779. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7816-8_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7816-8_23

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7815-1

  • Online ISBN: 978-1-4939-7816-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics